and were significantly more likely to remain in the therapeutic range during treatment (66% vs 42% of tests) than were patients on the aPTT-based protocol. There was no significant difference in ...
reagents were used for the anti-Xa assay. For these assays, aPTT levels of 51–100 seconds corresponded to a therapeutic anti-Xa range of 0.3 to 0.7 IU/mL. Clinically reported values were used ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果